tirzepatide ruling court on A federal court in Delaware has dismissed Eli Lilly's lawsuit against Strive Tirzepatide for Medical Weight Loss

Tirzepatide, a dual-action GLP-1 and GIP receptor agonist, shows promise in reducing liver fat accumulation and improving metabolic markers associated with fatty liver disease

Dehydration during exercise isn't just about water loss, it's an electrolyte ga

But while these medications are game-changers, what you eat still matters a lot.

Both are considered chronic conditions that need to be managed over an individuals lifetime. GLP-1 for Diabetes If you are using a GLP-1 for diabetes management, do not stop the medication without speaking to your doctor first

Ozempic accusations were once again thrown at the Kaling who was once revered as an example of body positivity.